These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16431965)

  • 21. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma.
    Hoshino A; Tanaka Y; Akiba H; Asakura Y; Mita Y; Sakurai T; Takaoka A; Nakaike S; Ishii N; Sugamura K; Yagita H; Okumura K
    Eur J Immunol; 2003 Apr; 33(4):861-9. PubMed ID: 12672051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential contributions of B7-1 and B7-2 to the development of murine experimental allergic conjunctivitis.
    Sumi T; Fukushima A; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
    Immunol Lett; 2007 Jan; 108(1):62-7. PubMed ID: 17109973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
    Schopf L; Luccioli S; Bundoc V; Justice P; Chan CC; Wetzel BJ; Norris HH; Urban JF; Keane-Myers A
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
    Br J Ophthalmol; 2006 Dec; 90(12):1535-41. PubMed ID: 16914468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H3 regulates the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yamazaki T; Akiba H; Okumura K; Yagita H; Ueno H
    Immunol Lett; 2007 Oct; 113(1):52-7. PubMed ID: 17825429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
    Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
    Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.
    Ishii N; Ndhlovu LC; Murata K; Sato T; Kamanaka M; Sugamura K
    Eur J Immunol; 2003 Sep; 33(9):2372-81. PubMed ID: 12938213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Azuma M; Yagita H; Ueno H
    Br J Ophthalmol; 2006 Aug; 90(8):1040-5. PubMed ID: 16613922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the interaction between IFN-gamma and IFN-gammaR in the effector phase of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Tsuru E; Ueno H
    Immunol Lett; 2006 Nov; 107(2):119-24. PubMed ID: 16987553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Sumi T; Fukuda K; Kumagai N; Nishida T; Takeuchi M; Taguchi O; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):705-14. PubMed ID: 17024440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis.
    Totsuka T; Kanai T; Uraushihara K; Iiyama R; Yamazaki M; Akiba H; Yagita H; Okumura K; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G595-603. PubMed ID: 12631559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation.
    Arestides RS; He H; Westlake RM; Chen AI; Sharpe AH; Perkins DL; Finn PW
    Eur J Immunol; 2002 Oct; 32(10):2874-80. PubMed ID: 12355440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of the OX40 ligand prolongs corneal allograft survival.
    Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
    Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis.
    Miyazaki D; Kuo CH; Tominaga T; Inoue Y; Ono SJ
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1626-35. PubMed ID: 19060266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Mittler RS; Yagita H; Ueno H
    J Immunol; 2005 Oct; 175(8):4897-903. PubMed ID: 16210591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.